SARS-CoV-2 (COVID-19) NTD Recombinant Protein

Supplier: Gentaur

0.01 GBP
Catalog: 223-10-079 Stock:On request
Product Size: 0.1 mg

You may also be interested


Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). In both SARS-CoV and SARS-CoV-2, the CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells3-5. The NTD of SARS-CoV-2 does not bind to ACE26, and the function of NTD in SARS-CoV-2 infection is not well understood. In other CoVs, the NTD may promote attachment by binding to sugar moieties7 and might play a role in the conformational change of S2 required for membrane fusion8. While most neutralizing antibodies target the RBD domain and block receptor binding, potent neutralizing antibodies targeting NTD were isolated from convalescent COVID19 patients9, identifying the NTD as an attractive candidate for vaccines and therapeutics. In addition, the NTD is a promising antigen for diagnostic tests, as there is only 53.5% homology between the NTD of SARS-CoV-2 and SARS-CoV10.



This recombinant protein may be stored as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.


  • Tested Applications: E
  • Applications: ELISA
  • Predicted Molecular Weight: The predicted molecular mass is ~36 kDa.
  • Physical state: Liquid
  • Buffer: This recombinant protein is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added._x000D__x000D_
  • Concentration: 0.5 mg/ml
  • NCBI official symbol: N/A
  • Accession #: QHD43416.1
  • Protein GI: N/A
  • NCBI gene ID#: 1791269090
  • NCBI official full name: surface glycoprotein
  • NCBI organism: Severe acute respiratory syndrome coronavirus 2
  • Peptide sequence: VNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKS
  • SWISSPROT #: N/A
  • Background Reference 1: Zhou, P., Yang, X., Wang, X. et al. Nature 579, 270–273. 2020.
  • Background Reference 2: Wu, F., Zhao, S., Yu, B. et al. Nature 579, 265–269. 2020.
  • Background Reference 3: Wrapp D, Wang N, Corbett KS, et al. bioRxiv. 2020.
  • Background Reference 4: Walls AC, Park YJ, Tortorici MA, et al. Cell. 181(2):281-292.e6. 2020.
  • Background Reference 5: N/A
  • Source: HEK293 cells
  • Species: SARS-CoV-2
  • By Source: Human Cells
  • By Species: Other
  • Fusion tag: N/A
  • Sequence: VNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKS
  • Biology activity: N/A
  • Purity: >95% by SDS Page

Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.

0 reviews for ProSci

Add a review

Your email address will not be published.